New Therapeutic Aspects of Inflammatory Cardiomyopathy

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|21|4|459-465

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.21, Iss.4, 2015-02, pp. : 459-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.